Stratifying Stroke Risk in Atrial Fibrillation: Beyond Clinical Risk Scores.
作者信息
Yaghi Shadi, Kamel Hooman
机构信息
From the Division of Stroke and Cerebrovascular Diseases, Department of Neurology, Warren Alpert Medical School of Brown University (S.Y.); and Department of Neurology (H.K.) and Feil Family Brain and Mind Research Institute (H.K.), Weill Cornell Medical College, New York, NY.
出版信息
Stroke. 2017 Oct;48(10):2665-2670. doi: 10.1161/STROKEAHA.117.017084. Epub 2017 Sep 15.
Abstract
摘要
相似文献
1
Stratifying Stroke Risk in Atrial Fibrillation: Beyond Clinical Risk Scores.心房颤动中风风险分层：超越临床风险评分
Stroke. 2017 Oct;48(10):2665-2670. doi: 10.1161/STROKEAHA.117.017084. Epub 2017 Sep 15.
2
Pro-atrial natriuretic peptide and prediction of atrial fibrillation and stroke: The Malmö Preventive Project.心钠素原与心房颤动及中风的预测：马尔默预防项目
Eur J Prev Cardiol. 2017 May;24(8):788-795. doi: 10.1177/2047487317693948. Epub 2017 Feb 14.
3
Atrial Fibrillation Detection: Fishing for An Irregular Heartbeat Before and After Stroke.心房颤动检测：中风前后探寻不规则心跳
Stroke. 2017 Oct;48(10):2671-2677. doi: 10.1161/STROKEAHA.117.017083. Epub 2017 Sep 15.
4
Causes of Ischemic Stroke in Patients with Non-Valvular Atrial Fibrillation.非瓣膜性心房颤动患者缺血性卒中的病因
Cerebrovasc Dis. 2016;42(3-4):196-204. doi: 10.1159/000445723. Epub 2016 Apr 26.
5
Comparison of 12 risk stratification schemes to predict stroke in patients with nonvalvular atrial fibrillation.12种风险分层方案对非瓣膜性心房颤动患者卒中预测的比较
Stroke. 2008 Jun;39(6):1901-10. doi: 10.1161/STROKEAHA.107.501825. Epub 2008 Apr 17.
6
Performance and Validation of a Novel Biomarker-Based Stroke Risk Score for Atrial Fibrillation.基于新型生物标志物的房颤卒中风险评分的性能和验证。
Circulation. 2016 Nov 29;134(22):1697-1707. doi: 10.1161/CIRCULATIONAHA.116.022802. Epub 2016 Aug 28.
7
Underuse of Oral Anticoagulants for Nonvalvular Atrial Fibrillation: Past, Present, and Future.非瓣膜性心房颤动口服抗凝剂的使用不足：过去、现在与未来
Tex Heart Inst J. 2016 Aug 1;43(4):287-90. doi: 10.14503/THIJ-16-5785. eCollection 2016 Aug.
8
Homocysteine in non-valvular atrial fibrillation: Role and clinical implications.非瓣膜性心房颤动中的同型半胱氨酸：作用和临床意义。
Clin Chim Acta. 2017 Dec;475:85-90. doi: 10.1016/j.cca.2017.10.012. Epub 2017 Oct 16.
9
What's New in Anticoagulation.抗凝治疗的新进展。
Tex Heart Inst J. 2016 Oct 1;43(5):419-421. doi: 10.14503/THIJ-16-5920. eCollection 2016 Oct.
10
Atrial Fibrillation and Mechanisms of Stroke: Time for a New Model.心房颤动与卒中机制：建立新模型的时候了。
Stroke. 2016 Mar;47(3):895-900. doi: 10.1161/STROKEAHA.115.012004. Epub 2016 Jan 19.
引用本文的文献
1
Atrial fibrillation with slow-ventricular response (AF-SVR): A literature review.伴有缓慢心室反应的心房颤动（AF-SVR）：文献综述。
J Med Access. 2025 Jun 30;9:27550834251342890. doi: 10.1177/27550834251342890. eCollection 2025 Jan-Dec.
2
Digital Twin Models in Atrial Fibrillation: Charting the Future of Precision Therapy?心房颤动中的数字孪生模型：描绘精准治疗的未来？
J Pers Med. 2025 Jun 16;15(6):256. doi: 10.3390/jpm15060256.
3
Catheter ablation for atrial fibrillation and risk of neurologic disease.房颤的导管消融与神经疾病风险
Heart Rhythm O2. 2024 Nov 9;6(1):32-38. doi: 10.1016/j.hroo.2024.11.004. eCollection 2025 Jan.
4
Slow blood-flow in the left atrial appendage is associated with stroke in atrial fibrillation patients.左心耳血流缓慢与房颤患者的中风有关。
Heliyon. 2024 Feb 28;10(5):e26858. doi: 10.1016/j.heliyon.2024.e26858. eCollection 2024 Mar 15.
5
Technology engagement is associated with higher perceived physical well-being in stroke patients prescribed smartwatches for atrial fibrillation detection.对于因检测心房颤动而配备智能手表的中风患者，技术参与度与更高的身体幸福感相关。
Front Digit Health. 2023 Dec 6;5:1243959. doi: 10.3389/fdgth.2023.1243959. eCollection 2023.
6
Mechanisms and Prediction of Ischemic Stroke in Atrial Fibrillation Patients.心房颤动患者缺血性卒中的机制与预测
J Clin Med. 2023 Oct 12;12(20):6491. doi: 10.3390/jcm12206491.
7
Can 24 h of ambulatory ECG be used to triage patients to extended monitoring?动态心电图 24 小时监测能否用于患者的延长监测分诊？
Ann Noninvasive Electrocardiol. 2023 Nov;28(6):e13090. doi: 10.1111/anec.13090. Epub 2023 Oct 6.
8
False Atrial Fibrillation Alerts from Smartwatches are Associated with Decreased Perceived Physical Well-being and Confidence in Chronic Symptoms Management.智能手表发出的错误房颤警报与慢性症状管理中感知到的身体健康状况下降和信心降低有关。
Cardiol Cardiovasc Med. 2023;7(2):97-107. doi: 10.26502/fccm.92920314. Epub 2023 Apr 3.
9
Effects of the ABC pathway on clinical outcomes in a secondary prevention population of Chinese patients with atrial fibrillation: A report from the Optimal Thromboprophylaxis in Elderly Chinese Patients with Atrial Fibrillation (ChiOTEAF) registry.ABC途径对中国房颤患者二级预防人群临床结局的影响：来自中国老年房颤患者最佳血栓预防（ChiOTEAF）注册研究的报告。
J Arrhythm. 2023 May 3;39(3):388-394. doi: 10.1002/joa3.12862. eCollection 2023 Jun.
10
ANMCO-SIMEU consensus document: appropriate management of atrial fibrillation in the emergency department.ANMCO-SIMEU共识文件：急诊科心房颤动的合理管理
Eur Heart J Suppl. 2023 May 18;25(Suppl D):D255-D277. doi: 10.1093/eurheartjsupp/suad110. eCollection 2023 May.
本文引用的文献
1
Prediction of Early Recurrent Thromboembolic Event and Major Bleeding in Patients With Acute Stroke and Atrial Fibrillation by a Risk Stratification Schema: The ALESSA Score Study.通过风险分层方案预测急性卒中合并心房颤动患者早期复发性血栓栓塞事件和大出血：ALESSA评分研究
Stroke. 2017 Mar;48(3):726-732. doi: 10.1161/STROKEAHA.116.015770. Epub 2017 Feb 9.
2
Left Atrial Appendage Thrombi Formation in Japanese Non-Valvular Atrial Fibrillation Patients During Anticoagulation Therapy - Warfarin vs. Direct Oral Anticoagulants.日本非瓣膜性心房颤动患者抗凝治疗期间左心耳血栓形成——华法林与直接口服抗凝剂的比较
Circ J. 2017 Apr 25;81(5):645-651. doi: 10.1253/circj.CJ-16-1089. Epub 2017 Feb 7.
3
Stroke and Mortality Risk in Patients With Various Patterns of Atrial Fibrillation: Results From the ENGAGE AF-TIMI 48 Trial (Effective Anticoagulation With Factor Xa Next Generation in Atrial Fibrillation-Thrombolysis in Myocardial Infarction 48).不同类型心房颤动患者的卒中与死亡风险：来自 ENGAGE AF-TIMI 48 试验（新型 Xa 因子抗凝在心房颤动-心肌梗死溶栓 48 中的疗效）的结果。
Circ Arrhythm Electrophysiol. 2017 Jan;10(1). doi: 10.1161/CIRCEP.116.004267.
4
Clinical Implications of Brief Device-Detected Atrial Tachyarrhythmias in a Cardiac Rhythm Management Device Population: Results from the Registry of Atrial Tachycardia and Atrial Fibrillation Episodes.心脏节律管理装置人群中短暂设备检测到的房性快速心律失常的临床意义：来自房性心动过速和心房颤动发作登记的结果。
Circulation. 2016 Oct 18;134(16):1130-1140. doi: 10.1161/CIRCULATIONAHA.115.020252.
5
Left atrial enlargement is an independent predictor of stroke and systemic embolism in patients with non-valvular atrial fibrillation.左心房扩大是非瓣膜性心房颤动患者发生中风和全身性栓塞的独立预测因素。
Sci Rep. 2016 Aug 3;6:31042. doi: 10.1038/srep31042.
6
Advanced interatrial block and ischemic stroke: The Atherosclerosis Risk in Communities Study.高度房间阻滞与缺血性卒中：社区动脉粥样硬化风险研究
Neurology. 2016 Jul 26;87(4):352-6. doi: 10.1212/WNL.0000000000002888. Epub 2016 Jun 24.
7
The ABC (age, biomarkers, clinical history) stroke risk score: a biomarker-based risk score for predicting stroke in atrial fibrillation.ABC（年龄、生物标志物、临床病史）卒中风险评分：一种基于生物标志物的房颤卒中预测风险评分。
Eur Heart J. 2016 May 21;37(20):1582-90. doi: 10.1093/eurheartj/ehw054. Epub 2016 Feb 25.
8
Inflammatory Markers and Outcomes After Lacunar Stroke: Levels of Inflammatory Markers in Treatment of Stroke Study.腔隙性卒中后的炎症标志物与预后：卒中治疗研究中的炎症标志物水平
Stroke. 2016 Mar;47(3):659-67. doi: 10.1161/STROKEAHA.115.012166.
9
The impact of atrial fibrillation type on the risk of thromboembolism, mortality, and bleeding: a systematic review and meta-analysis.心房颤动类型对血栓栓塞、死亡率和出血风险的影响：系统评价和荟萃分析。
Eur Heart J. 2016 May 21;37(20):1591-602. doi: 10.1093/eurheartj/ehw007. Epub 2016 Feb 16.
10
Biomarkers of inflammation and risk of cardiovascular events in anticoagulated patients with atrial fibrillation.房颤抗凝患者炎症生物标志物与心血管事件风险
Heart. 2016 Apr;102(7):508-17. doi: 10.1136/heartjnl-2015-308887. Epub 2016 Feb 2.
Zotero 插件